Fairtree Asset Management Pty Ltd Buys New Stake in Humana Inc. (NYSE:HUM)

Fairtree Asset Management Pty Ltd purchased a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 2,179 shares of the insurance provider's stock, valued at approximately $553,000.

Other large investors have also recently made changes to their positions in the company. FPC Investment Advisory Inc. purchased a new position in shares of Humana during the 4th quarter worth about $27,000. Centricity Wealth Management LLC purchased a new position in shares of Humana during the 4th quarter worth about $30,000. LFA Lugano Financial Advisors SA boosted its stake in shares of Humana by 56.3% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the period. OFI Invest Asset Management purchased a new position in shares of Humana during the 4th quarter worth about $33,000. Finally, Transce3nd LLC purchased a new position in shares of Humana during the 4th quarter worth about $38,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Performance

Shares of HUM stock traded up $2.83 during trading hours on Friday, hitting $232.91. The company's stock had a trading volume of 2,524,287 shares, compared to its average volume of 1,781,544. The company has a 50 day moving average of $257.92 and a 200 day moving average of $267.13. The stock has a market cap of $28.11 billion, a PE ratio of 23.41, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12-month low of $212.45 and a 12-month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business's revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the prior year, the firm earned $7.23 EPS. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.52%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.

Wall Street Analyst Weigh In

HUM has been the subject of a number of research analyst reports. Raymond James upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a report on Thursday, May 1st. Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Truist Financial reduced their price target on shares of Humana from $325.00 to $305.00 and set a "hold" rating for the company in a report on Monday, May 12th. Barclays boosted their price target on shares of Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Finally, Oppenheimer boosted their price target on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a report on Thursday, May 1st. Seventeen research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $286.81.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.